Skip to main content
NVDA-0.34%AAPL+1.26%GOOGL-2.28%MSFT+0.02%AMZN+0.13%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.24%TSLA-0.53%SKHY+7.05%MU-1.24%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.56%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.66%0005.HK-0.78%HSBA.L-1.36%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.12%CHFJPY-1.62%AUDJPY-1.44%USDJPY-1.42%EURJPY-1.33%CADJPY-1.27%GBPJPY-1.26%NZDCAD-0.87%GBPNZD+0.86%EURNZD+0.83%NZDUSD-0.73%AUDNZD+0.71%NZDCHF-0.53%GBPTRY+0.41%USDNOK+0.38%USDZAR+0.35%GBPCHF+0.34%CADCHF+0.33%GBPHKD+0.32%EURNOK+0.31%EURCHF+0.28%GBPMXN-0.28%GBPZAR+0.28%EURZAR+0.27%CHFNOK+0.23%USDCHF+0.21%AUDCAD-0.20%SGDJPY+0.20%USDTHB+0.19%AUDCHF+0.18%USDSEK+0.18%AUDNOK+0.16%USDILS+0.16%GBPAUD+0.16%USDPLN+0.16%GBPUSD+0.16%PLNJPY+0.15%AUDDKK-0.15%USDCAD-0.14%NZDSGD+0.12%USDMXN+0.12%EURAUD+0.12%USDSGD+0.12%AUDSGD-0.11%USDTRY+0.11%NZDMXN+0.10%EURSEK+0.10%EURHKD-0.09%EURUSD+0.09%USDDKK+0.08%EURPLN+0.08%NOKJPY-0.07%EURCNH-0.07%EURCAD-0.06%EURCZK-0.06%EURGBP-0.05%USDCOP-0.04%GBPSGD+0.04%CHFSGD-0.04%EURSGD+0.04%CHFSEK+0.03%AUDUSD-0.02%USDHKD+0.01%USDCNH-0.01%GBPCAD-0.01%EURDKK0.00%HG1-3.91%XPTUSD-2.57%COFFEE-2.34%SUGAR+2.02%XAGUSD-1.98%GAGUSD-1.98%COCOA-1.62%COTTON+0.94%XAUUSD-0.53%GAUUSD-0.53%C1+0.52%S1+0.50%BTCUSD-0.46%ETHUSD-0.03%USDTUSD-0.08%XRPUSD-1.42%SOLUSD-0.48%TRXUSDT+0.45%ZECUSDT-1.79%DOGEUSD-1.24%XMRUSDT-1.61%LINKUSD-0.17%XLMUSD-1.06%BCHUSDT-2.41%LTCUSD-1.69%UNIUSD-2.01%TONUSD+24.88%HBARUSDT-1.25%SUIUSD-1.54%TAOUSDT-1.07%AAVEUSD-2.05%DOTUSDT-2.18%ICPUSDT-1.04%ONDOUSDT-2.03%WLDUSDT-1.71%ATOMUSDT-2.60%ARBUSDT-0.40%JUPUSDT-2.96%INJUSDT-2.21%STXUSDT-3.07%FETUSDT-2.74%TIAUSDT-0.60%SEIUSDT-3.91%PYTHUSDT-1.42%IMXUSDT-2.67%WIFUSDT-2.93%GRTUSDT-2.38%OPUSDT-1.99%POLUSDT-7.03%IOTAUSDT-2.30%AXSUSDT-1.93%FARTCOINUSDT-1.83%EOSUSDT-0.06%DYDXUSDT-0.47%ORDIUSDT+0.42%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.34%AAPL+1.26%GOOGL-2.28%MSFT+0.02%AMZN+0.13%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.24%TSLA-0.53%SKHY+7.05%MU-1.24%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.56%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.66%0005.HK-0.78%HSBA.L-1.36%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.12%CHFJPY-1.62%AUDJPY-1.44%USDJPY-1.42%EURJPY-1.33%CADJPY-1.27%GBPJPY-1.26%NZDCAD-0.87%GBPNZD+0.86%EURNZD+0.83%NZDUSD-0.73%AUDNZD+0.71%NZDCHF-0.53%GBPTRY+0.41%USDNOK+0.38%USDZAR+0.35%GBPCHF+0.34%CADCHF+0.33%GBPHKD+0.32%EURNOK+0.31%EURCHF+0.28%GBPMXN-0.28%GBPZAR+0.28%EURZAR+0.27%CHFNOK+0.23%USDCHF+0.21%AUDCAD-0.20%SGDJPY+0.20%USDTHB+0.19%AUDCHF+0.18%USDSEK+0.18%AUDNOK+0.16%USDILS+0.16%GBPAUD+0.16%USDPLN+0.16%GBPUSD+0.16%PLNJPY+0.15%AUDDKK-0.15%USDCAD-0.14%NZDSGD+0.12%USDMXN+0.12%EURAUD+0.12%USDSGD+0.12%AUDSGD-0.11%USDTRY+0.11%NZDMXN+0.10%EURSEK+0.10%EURHKD-0.09%EURUSD+0.09%USDDKK+0.08%EURPLN+0.08%NOKJPY-0.07%EURCNH-0.07%EURCAD-0.06%EURCZK-0.06%EURGBP-0.05%USDCOP-0.04%GBPSGD+0.04%CHFSGD-0.04%EURSGD+0.04%CHFSEK+0.03%AUDUSD-0.02%USDHKD+0.01%USDCNH-0.01%GBPCAD-0.01%EURDKK0.00%HG1-3.91%XPTUSD-2.57%COFFEE-2.34%SUGAR+2.02%XAGUSD-1.98%GAGUSD-1.98%COCOA-1.62%COTTON+0.94%XAUUSD-0.53%GAUUSD-0.53%C1+0.52%S1+0.50%BTCUSD-0.46%ETHUSD-0.03%USDTUSD-0.08%XRPUSD-1.42%SOLUSD-0.48%TRXUSDT+0.45%ZECUSDT-1.79%DOGEUSD-1.24%XMRUSDT-1.61%LINKUSD-0.17%XLMUSD-1.06%BCHUSDT-2.41%LTCUSD-1.69%UNIUSD-2.01%TONUSD+24.88%HBARUSDT-1.25%SUIUSD-1.54%TAOUSDT-1.07%AAVEUSD-2.05%DOTUSDT-2.18%ICPUSDT-1.04%ONDOUSDT-2.03%WLDUSDT-1.71%ATOMUSDT-2.60%ARBUSDT-0.40%JUPUSDT-2.96%INJUSDT-2.21%STXUSDT-3.07%FETUSDT-2.74%TIAUSDT-0.60%SEIUSDT-3.91%PYTHUSDT-1.42%IMXUSDT-2.67%WIFUSDT-2.93%GRTUSDT-2.38%OPUSDT-1.99%POLUSDT-7.03%IOTAUSDT-2.30%AXSUSDT-1.93%FARTCOINUSDT-1.83%EOSUSDT-0.06%DYDXUSDT-0.47%ORDIUSDT+0.42%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%
AT

AtriCure, Inc. (ATRC)

NASDAQ • Healthcare

$53.03
-$0.69 (-1.3%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$53.16
Day Range$51.97 - $53.71
Avg. Volume (3M)838.3K
Market Cap$2.6B
P/E Ratio252.5
52 Week Range
$25.36$55.72
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$153.6M100%
Gross Profitminus cost of goods$118.6M77%
Operating Incomeminus R&D and overhead$9.6M6%
Net Incomeminus taxes and the rest$8.9M6%

In plain terms: out of every $100 in revenue, AtriCure, Inc. keeps $6 as net profit.

Fundamentals & Financials

Revenue (TTM)
$569.6M
Net Income (TTM)
$10.5M
EPS (TTM)
$0.21
ROA (TTM)
1.56%
Current Ratio
4.22
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+249.9%Q1 2026$0.06
+103.1%Q2 2026$0
+10878.4%Q3 2026$0.18
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +10878.4%

AtriCure topped revenue expectations in the second fiscal quarter of 2026, reported July 23, 2026, as revenue rose 12.8% to about $153.6 million versus about $151.8 million expected, a 1.2% beat, and up from about $136.1 million a year ago. Sales were concentrated in the United States, which brought in about $125.6 million and grew 13.6%, while Asia Pacific climbed 15.4% to about $8.6 million. Gross profit came in at about $118.6 million, with gross margin near 77%, leaving the quarter’s profitability profile largely steady on the top-line mix. Operating cash flow was about $22.2 million, and the company repurchased $314,000 of stock. For the next period, consensus calls for EPS of $-0.04 on revenue of $151.2 million.

View full earnings history

About AtriCure, Inc.

AtriCure, Inc. develops and sells medical devices used in cardiac surgery and electrophysiology, making it part of the healthcare equipment field and listed on NASDAQ as ATRC. Its portfolio centers on ablation, appendage management, and soft-tissue closure, and it generated $534.5 million of revenue in FY2025.

Name
AtriCure, Inc.
CEO
Michael H. Carrel
Website
www.atricure.com
Industry
Healthcare
Year Founded
2000
Employees
1,350

Today's Snapshot

AI-generated

The day ended with ATRC 1.3% lower at 53.03, while its sector was flat. Volume was about half as much again as its usual level.

Trading Volume

Above 10d avg 986.1K

1.5M

vs S&P 500 Today

Underperforming Market

-0.88%

Updated: September 9, 2026 at 20:23 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
ATRC displays a constructive technical profile driven by a strong trend and momentum. ADX is well above 40, indicating a robust directional move, while MACD and CCI are strongly positive and short- and medium-term moving averages sit comfortably below the current price, with the 200-day average also well lower, confirming broad support. RSI is elevated and suggests overbought conditions, and OBV does not confirm the price strength, while volatility is moderate. Technical takeaway: trend and momentum support a bullish technical stance.
All signals
  • EMA (5 indicators)$36.67 - $50.97
    Buy
  • RSI (14)74.25
    Sell
  • Stochastic %K (14, 3, 3)75.88
    Neutral
  • MACD Level (12, 26)3.43
    Buy

Peers & Related Assets

TXG10x Genomics, Inc.
$67.29+2.6%
NVCRNovocure Ltd
$15.63-7.2%
LMATLeMaitre Vascular, Inc.
$79.47-0.1%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
AZTAAzenta, Inc.
$30.15-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.